DENNIS DOMINGUEZ: Open Payments
NPI 1225063811 · EL CAJON, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$940 in 10 payments from 9 companies in 2025. Trend: 2023 $230 · 2024 $411 · 2025 $940
Food & beverage: $940
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 1 | $150 |
| Lilly USA, LLC | 2 | $140 |
| Exelixis Inc. | 1 | $132 |
| UCB, Inc. | 1 | $125 |
| ABBVIE INC. | 1 | $125 |
| Amgen Inc. | 1 | $122 |
| Novo Nordisk Inc | 1 | $78 |
| Dexcom, Inc. | 1 | $47 |
| Merck Sharp & Dohme LLC | 1 | $20 |
Products named: INVEGA TRINZA, CABOMETYX, Fintepla, QULIPTA, EVENITY, Wegovy, ZEPBOUND, Dexcom G6 Transmitter.
Industry payments across CA — which companies pay providers there.
